Edge lifting observed during patch manufacturing – inspection finding risk


Published on 03/01/2026

Investigation of Edge Lifting Issues During Transdermal Patch Manufacturing

Edge lifting observed during patch manufacturing represents a significant concern among pharmaceutical professionals engaged in the creation of transdermal products. This issue can lead to product defects that not only jeopardize product integrity but also invite regulatory scrutiny, impacting a firm’s market standing and compliance posture. This article will guide you through a structured approach to investigate, analyze and rectify edge lifting incidents effectively.

By following the outlined steps, readers will learn how to recognize the symptoms of edge lifting, identify likely causes, implement immediate actions, and develop a robust CAPA strategy tailored to restore compliance and maintain product quality.

Symptoms/Signals on the Floor or in the Lab

The initial signals indicating edge lifting during transdermal patch manufacturing can manifest in various ways. Symptoms may include:

  • Visible separation between the edge of the patch and the backing layer.
  • Complaints from quality control (QC) regarding non-conforming
patches.
  • Increased OOS (Out of Specification) reports for adhesion quality.
  • Customer complaints post-manufacture highlighting adhesive failure.
  • Inconsistent peel strength values during testing phases.
  • Recognizing these signals promptly is essential. Continuous monitoring and robust visual inspections can help identify the onset of edge lifting, allowing teams to act quickly before the issue escalates.

    Likely Causes

    Understanding the potential causes of edge lifting is crucial for directing investigative efforts. Utilizing the “5 Ms” framework can help categorize these causes effectively:

    Category Likely Causes
    Materials Use of substandard adhesive, incompatible liners or substrates.
    Method Inadequate adhesion application techniques, incorrect pressure during lamination.
    Machine Equipment malfunction, improper calibration of applicators.
    Man Operator errors during manufacturing or quality control processes.
    Measurement Inaccurate monitoring of environmental conditions such as humidity and temperature.
    Environment Inappropriate storage conditions leading to adhesive degradation.

    By exploring each category, manufacturers can develop hypotheses about the root causes of edge lifting effectively.

    Immediate Containment Actions (first 60 minutes)

    Once edge lifting is observed, immediate containment is necessary to prevent producing further non-conforming patches. Within the first hour:

    1. **Halt production**: Stop all current manufacturing processes to prevent additional defects.
    2. **Isolate affected batches**: Segregate any batches that may have been impacted, as well as the materials used during the time span when edge lifting was first noticed.
    3. **Notify the QC team**: Alert the quality control function about the situation to initiate an extensive inspection of the affected batches.
    4. **Conduct initial observations**: Gather initial data and describe the observed edge lifting in detail, noting the timing, environment, and any anomalies.
    5. **Communicate findings**: Ensure all relevant teams (QA, Manufacturing, Engineering) are informed about the findings for a coordinated investigation.

    Investigation Workflow (data to collect + how to interpret)

    Executing a well-structured investigation workflow ensures that critical data is collected and analyzed systematically:

    1. **Define the scope of investigation**: Identify the specific production lots / batches affected.
    2. **Collect data from production records**: Gather batch records, equipment logs, environmental monitoring data, and operator notes.
    3. **Review the QC testing results**: Analyze peel adhesion test results, physical inspections, and any deviations reported.
    4. **Analyze environmental monitoring records**: Look for anomalies in humidity, temperature, and particulate contamination at the time of manufacturing.
    5. **Consult with operators**: Conduct interviews to understand if any abnormal actions were taken during the manufacturing process.
    6. **Perform visual inspections and testing on isolated batches**: Inspect and test samples from the affected batches to collect empirical data regarding the edge lifting phenomenon.

    Employing this systematic approach will provide a comprehensive picture that will aid in determining the likely root causes of the edge lifting issue.

    Root Cause Tools (5-Why, Fishbone, Fault Tree) and when to use which

    To ascertain the true underlying factors initiating edge lifting, distinct root cause analysis tools can be employed:

    • 5-Why Analysis: This straightforward approach is effective for quickly identifying root causes by repeatedly asking “why” until reaching the fundamental issue. Ideal for isolated incidents where causes seem apparent.
    • Fishbone Diagram (Ishikawa): This visual tool structures the investigation around categories (like the “Ms”) and is useful when multiple potential causes must be explored simultaneously. It helps visualize relationships amongst causes effectively.
    • Fault Tree Analysis: This tree-structured diagram provides a methodical approach to determine failure modes of a process. Use it when edge lifting may result from complex or systemic issues.

    Choosing the right tool based on the circumstances of the investigation can provide clarity and direction in identifying the primary cause of the edge lifting issue.

    CAPA Strategy (correction, corrective action, preventive action)

    Establishing a comprehensive CAPA strategy is vital to mitigate edge lifting incidents effectively. This strategy involves three key components:

    1. Correction: Adjust any immediate actions taken to ensure product quality, such as re-inspecting and segregating affected products, and managing materials put on hold.
    2. Corrective Action: Implement permanent changes to processes and training if deviations from standard operating procedures (SOPs) are identified. This could include retraining personnel on proper application methods or equipment calibration.
    3. Preventive Action: Develop strategies to foresee similar issues in the future. This might involve new monitoring protocols, altering supplier contracts for material quality assurance, or conducting routine audits of manufacturing processes.

    Thorough documentation of each CAPA and their effectiveness is critical for regulatory compliance and continuous improvement.

    Control Strategy & Monitoring (SPC/trending, sampling, alarms, verification)

    A robust Control Strategy should be formulated to monitor and manage the impact of edge lifting on product quality. Key components include:

    • Statistical Process Control (SPC): Implement real-time monitoring of adhesion values with established control limits. Utilize control charts to visualize trends and deviations over time.
    • Sampling Plans: Specify how often and how many patches are to be sampled during production. This will facilitate timely identification of edge lifting before reaching full batch release.
    • Alarm Systems: Set alerts for conditions that may lead to edge lifting (e.g., humidity or temperature fluctuations beyond acceptable ranges).
    • Verification Processes: Regularly review and validate the effectiveness of the control measures in place, making adjustments as necessary based on data trends.

    Maintaining a proactive stance on monitoring will further fortify the quality and reliability of produced patches.

    Validation / Re-qualification / Change Control impact (when needed)

    Depending on the findings of the investigation and CAPA implementation, it may be necessary to perform validation, re-qualification, or change control activities. Consider these scenarios:

    Related Reads

    • **Validation**: If the root cause is determined to be associated with a new material or process, validate the entire manufacturing procedure again to ensure compliance with applicable regulations.
    • **Re-qualification**: Equipment involved in the manufacture must be re-qualified if it was involved in generating non-conforming product or if maintenance actions were required.
    • **Change Control**: Document any proposed changes formally through a change control process, especially if altering processes, suppliers, or materials is necessary to prevent edge lifting occurrences in the future.

    These activities ensure ongoing compliance and product safety.

    Inspection Readiness: what evidence to show (records, logs, batch docs, deviations)

    Finally, maintaining inspection readiness is essential for handling regulatory scrutiny. Evidence to prepare includes:

    • Batch Production Records: Detailed and accurate records should be maintained, showcasing the entire manufacturing history of the affected batches.
    • Logs and Reports: Ensure environmental monitoring logs, training records, and equipment calibration documentation are up-to-date and easily accessible.
    • Deviation Reports: All investigations, symptoms, findings, and CAPAs should be documented through formal deviation reports to ensure traceability and accountability.

    Having this documentation readily available demonstrates a proactive approach to quality assurance and compliance.

    FAQs

    What is edge lifting in transdermal patch manufacturing?

    Edge lifting refers to the separation of the adhesive edge of a transdermal patch from its backing, which can compromise adhesion and product efficacy.

    How can I detect edge lifting during production?

    Visual inspections, monitoring peel adhesion values, and reviewing complaints from customers regarding patch integrity are essential methods for detecting edge lifting.

    What immediate actions should I take if edge lifting is observed?

    Stop production, isolate affected batches, notify your QC team, and begin gathering initial data for investigation.

    What root cause analysis tools should I use for edge lifting?

    The 5-Why analysis, Fishbone diagram, and Fault Tree analysis are effective tools for identifying root causes of edge lifting incidents.

    What factors can contribute to edge lifting?

    Potential causes include materials quality, application methods, equipment issues, operator errors, measurement inaccuracies, and environmental conditions.

    How do I document CAPA actions relating to edge lifting?

    Each CAPA must include documentation of corrections made, the corrective actions taken for root cause resolution, and preventive measures implemented to avoid recurrence.

    How often should monitoring be conducted post-incident?

    Continuous monitoring should be in place, with regular reviews of SPC data, sampling plans, and alarm systems as part of your ongoing quality management strategy.

    What types of records are important for inspection readiness?

    Maintain comprehensive batch production records, environmental logs, equipment calibration documents, operator training records, and deviation reports for inspection readiness.

    What should be included in a change control process?

    Change control should include a rationale for the change, documentation of the proposed change, impact assessments, and approval signatures from quality assurance personnel.

    How can SPC help manage edge lifting issues?

    Statistical Process Control (SPC) can provide insights into process variations over time, allowing for timely interventions before edge lifting actions result in product non-conformance.

    What is the role of validation in the context of edge lifting?

    Validation ensures that manufacturing processes and materials yield consistent, high-quality products. If edge lifting is linked to changes in processes or raw materials, re-validation is essential.

    Why is documentation critical during an edge lifting investigation?

    Documentation provides evidence of investigation efforts and CAPA implementations, ensuring compliance with regulatory expectations and protecting the organization’s integrity.

    Pharma Tip:  Dose delivery inconsistency during patch manufacturing – process vs material root cause